TY - BOOK PY - 2012 DA - 2012// TI - European guidelines for treatment of HIV infected adults in Europe [version 6.1 November ] ID - ref1 ER - TY - BOOK PY - 2012 DA - 2012// TI - Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents PB - Department of Health and Human Services CY - USA ID - ref2 ER - TY - JOUR AU - van Griensven, J. AU - Zachariah, R. AU - Rasschaert, F. AU - Mugabo, J. AU - Atte, E. F. AU - Reid, T. PY - 2010 DA - 2010// TI - Stavudine- and nevirapine-related drug toxicity while on generic fixed-dose antiretroviral treatment: incidence, timing and risk factors in a three-year cohort in kigali, rwanda JO - Trans R Soc Trop Med Hyg VL - 104 UR - https://doi.org/10.1016/j.trstmh.2009.07.009 DO - 10.1016/j.trstmh.2009.07.009 ID - van Griensven2010 ER - TY - JOUR AU - Manosuthi, W. AU - Sungkanuparph, S. AU - Tansuphaswadikul, S. AU - Inthong, Y. AU - Prasithsirikul, W. AU - Chottanapund, S. AU - Mankatitham, W. AU - Chimsuntorn, S. AU - Sittibusaya, C. AU - Moolasart, V. PY - 2007 DA - 2007// TI - Incidence and risk factors of nevirapine-associated skin rashes among HIV-infected patients with CD4 cell counts <250 cells/microL JO - Int J STD AIDS VL - 18 UR - https://doi.org/10.1258/095646207782212289 DO - 10.1258/095646207782212289 ID - Manosuthi2007 ER - TY - JOUR AU - Antinori, A. AU - Baldini, F. AU - Girardi, E. AU - Cingolani, A. AU - Zaccarelli, M. AU - Di Giambenedetto, S. AU - Barracchini, A. AU - De Longis, P. AU - Murri, R. AU - Tozzi, V. PY - 2001 DA - 2001// TI - Female sex and the use of anti-allergic agents increase the risk of developing cutaneous rash associated with nevirapine therapy JO - AIDS VL - 15 UR - https://doi.org/10.1097/00002030-200108170-00018 DO - 10.1097/00002030-200108170-00018 ID - Antinori2001 ER - TY - JOUR AU - Yozviak, J. L. AU - Doerfler, R. E. AU - Woodward, W. C. PY - 2001 DA - 2001// TI - Effectiveness and tolerability of nevirapine, stavudine, and lamivudine in clinical practice JO - HIV Clin Trials VL - 2 UR - https://doi.org/10.1310/T0RR-TGY0-8QWB-8YT2 DO - 10.1310/T0RR-TGY0-8QWB-8YT2 ID - Yozviak2001 ER - TY - JOUR AU - Mehta, U. AU - Maartens, G. PY - 2007 DA - 2007// TI - Is it safe to switch between efavirenz and nevirapine in the event of toxicity? JO - Lancet Infect Dis VL - 7 UR - https://doi.org/10.1016/S1473-3099(07)70262-1 DO - 10.1016/S1473-3099(07)70262-1 ID - Mehta2007 ER - TY - JOUR AU - Taylor, S. AU - Boffito, M. AU - Khoo, S. AU - Smit, E. AU - Back, D. PY - 2007 DA - 2007// TI - Stopping antiretroviral therapy JO - AIDS VL - 21 UR - https://doi.org/10.1097/QAD.0b013e3281c61394 DO - 10.1097/QAD.0b013e3281c61394 ID - Taylor2007 ER - TY - JOUR AU - Johnson, V. A. AU - Brun-Vezinet, F. AU - Clotet, B. AU - Gunthard, H. F. AU - Kuritzkes, D. R. AU - Pillay, D. AU - Schapiro, J. M. AU - Richman, D. D. PY - 2009 DA - 2009// TI - Update of the drug resistance mutations in HIV-1: December 2009 JO - Top HIV Med VL - 17 ID - Johnson2009 ER - TY - JOUR AU - Antinori, A. AU - Zaccarelli, M. AU - Cingolani, A. AU - Forbici, F. AU - Rizzo, M. G. AU - Trotta, M. P. AU - Di Giambenedetto, S. AU - Narciso, P. AU - Ammassari, A. AU - Girardi, E. PY - 2002 DA - 2002// TI - Cross-resistance among nonnucleoside reverse transcriptase inhibitors limits recycling efavirenz after nevirapine failure JO - AIDS Res Hum Retroviruses VL - 18 UR - https://doi.org/10.1089/08892220260190308 DO - 10.1089/08892220260190308 ID - Antinori2002 ER - TY - BOOK PY - 2008 DA - 2008// TI - Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents PB - Department of Health and Human Services CY - USA ID - ref11 ER - TY - JOUR AU - Arrive, E. AU - Newell, M. L. AU - Ekouevi, D. K. AU - Chaix, M. L. AU - Thiebaut, R. AU - Masquelier, B. AU - Leroy, V. AU - Perre, P. V. AU - Rouzioux, C. AU - Dabis, F. PY - 2007 DA - 2007// TI - Prevalence of resistance to nevirapine in mothers and children after single-dose exposure to prevent vertical transmission of HIV-1: a meta-analysis JO - Int J Epidemiol VL - 36 UR - https://doi.org/10.1093/ije/dym104 DO - 10.1093/ije/dym104 ID - Arrive2007 ER - TY - JOUR AU - McIntyre, J. A. AU - Hopley, M. AU - Moodley, D. AU - Eklund, M. AU - Gray, G. E. AU - Hall, D. B. AU - Robinson, P. AU - Mayers, D. AU - Martinson, N. A. PY - 2009 DA - 2009// TI - Efficacy of short-course AZT plus 3TC to reduce nevirapine resistance in the prevention of mother-to-child HIV transmission: a randomized clinical trial JO - PLoS Med VL - 6 UR - https://doi.org/10.1371/journal.pmed.1000172 DO - 10.1371/journal.pmed.1000172 ID - McIntyre2009 ER - TY - JOUR AU - Arrive, E. AU - Chaix, M. L. AU - Nerrienet, E. AU - Blanche, S. AU - Rouzioux, C. AU - Coffie, P. A. AU - Kruy Leang, S. AU - McIntyre, J. AU - Avit, D. AU - Srey, V. H. PY - 2009 DA - 2009// TI - Tolerance and viral resistance after single-dose nevirapine with tenofovir and emtricitabine to prevent vertical transmission of HIV-1 JO - AIDS VL - 23 ID - Arrive2009 ER - TY - JOUR AU - Fox, Z. AU - Phillips, A. AU - Cohen, C. AU - Neuhaus, J. AU - Baxter, J. AU - Emery, S. AU - Hirschel, B. AU - Hullsiek, K. H. AU - Stephan, C. AU - Lundgren, J. PY - 2008 DA - 2008// TI - Viral resuppression and detection of drug resistance following interruption of a suppressive non-nucleoside reverse transcriptase inhibitor-based regimen JO - AIDS VL - 22 UR - https://doi.org/10.1097/QAD.0b013e328311d16f DO - 10.1097/QAD.0b013e328311d16f ID - Fox2008 ER - TY - JOUR AU - El-Sadr, W. M. AU - Lundgren, J. D. AU - Neaton, J. D. AU - Gordin, F. AU - Abrams, D. AU - Arduino, R. C. AU - Babiker, A. AU - Burman, W. AU - Clumeck, N. AU - Cohen, C. J. PY - 2006 DA - 2006// TI - CD4+ Count-guided interruption of antiretroviral treatment JO - N Engl J Med VL - 355 UR - https://doi.org/10.1056/NEJMoa062360 DO - 10.1056/NEJMoa062360 ID - El-Sadr2006 ER - TY - JOUR AU - Hanna, G. J. AU - Johnson, V. A. AU - Kuritzkes, D. R. AU - Richman, D. D. AU - Brown, A. J. AU - Savara, A. V. AU - Hazelwood, J. D. AU - D'Aquila, R. T. PY - 2000 DA - 2000// TI - Patterns of resistance mutations selected by treatment of human immunodeficiency virus type 1 infection with zidovudine, didanosine, and nevirapine JO - J Infect Dis VL - 181 UR - https://doi.org/10.1086/315329 DO - 10.1086/315329 ID - Hanna2000 ER - TY - JOUR AU - Sungkanuparph, S. AU - Manosuthi, W. AU - Kiertiburanakul, S. AU - Piyavong, B. AU - Chumpathat, N. AU - Chantratita, W. PY - 2007 DA - 2007// TI - Options for a second-line antiretroviral regimen for HIV type 1-infected patients whose initial regimen of a fixed-dose combination of stavudine, lamivudine, and nevirapine fails JO - Clin Infect Dis VL - 44 UR - https://doi.org/10.1086/510745 DO - 10.1086/510745 ID - Sungkanuparph2007 ER - TY - JOUR PY - 2006 DA - 2006// TI - British HIV association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2006) JO - HIV Med VL - 7 UR - https://doi.org/10.1111/j.1468-1293.2006.00424.x DO - 10.1111/j.1468-1293.2006.00424.x ID - ref19 ER - TY - JOUR AU - Kikaire, B. AU - Khoo, S. AU - Walker, A. S. AU - Ssali, F. AU - Munderi, P. AU - Namale, L. AU - Reid, A. AU - Gibb, D. M. AU - Mugyenyi, P. AU - Grosskurth, H. PY - 2007 DA - 2007// TI - Nevirapine clearance from plasma in african adults stopping therapy: a pharmacokinetic substudy JO - AIDS VL - 21 UR - https://doi.org/10.1097/QAD.0b013e3280121801 DO - 10.1097/QAD.0b013e3280121801 ID - Kikaire2007 ER - TY - JOUR AU - Mackie, N. E. AU - Fidler, S. AU - Tamm, N. AU - Clarke, J. R. AU - Back, D. AU - Weber, J. N. AU - Taylor, G. P. PY - 2004 DA - 2004// TI - Clinical implications of stopping nevirapine-based antiretroviral therapy: relative pharmacokinetics and avoidance of drug resistance JO - HIV Med VL - 5 UR - https://doi.org/10.1111/j.1468-1293.2004.00208.x DO - 10.1111/j.1468-1293.2004.00208.x ID - Mackie2004 ER - TY - JOUR AU - Sungkanuparph, S. AU - Techasathit, W. AU - Utaipiboon, C. AU - Chasombat, S. AU - Bhakeecheep, S. AU - Leechawengwongs, M. AU - Ruxrungtham, K. AU - Phanuphak, P. PY - 2010 DA - 2010// TI - Thai national guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents 2010 JO - Asian Biomed VL - 4 ID - Sungkanuparph2010 ER - TY - JOUR AU - Bangsberg, D. R. PY - 2006 DA - 2006// TI - Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression JO - Clin Infect Dis VL - 43 UR - https://doi.org/10.1086/507526 DO - 10.1086/507526 ID - Bangsberg2006 ER - TY - JOUR AU - Paterson, D. L. AU - Swindells, S. AU - Mohr, J. AU - Brester, M. AU - Vergis, E. N. AU - Squier, C. AU - Wagener, M. M. AU - Singh, N. PY - 2000 DA - 2000// TI - Adherence to protease inhibitor therapy and outcomes in patients with HIV infection JO - Ann Intern Med VL - 133 UR - https://doi.org/10.7326/0003-4819-133-1-200007040-00004 DO - 10.7326/0003-4819-133-1-200007040-00004 ID - Paterson2000 ER -